tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market

Compare ARS Pharmaceuticals (SPRY) vs. Competitors

Compare
550 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ARS Pharmaceuticals
$11.09
$1.17B
-13.69
-7.66%
4 Buy
0 Hold
0 Sell
Strong Buy
Trevi Therapeutics
$13.47
$1.47B
-28.98
181.68%
9 Buy
0 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$11.52
$1.10B
-6.65
5.98%
11 Buy
1 Hold
0 Sell
Strong Buy
Pharming Group
$18.16
$1.28B
1,261.11
93.60%
2 Buy
0 Hold
0 Sell
Moderate Buy
Maze Therapeutics, Inc.
$41.39
$1.98B
-17.66
149.59%
6 Buy
0 Hold
0 Sell
Strong Buy
Sionna Therapeutics, Inc.
$38.85
$1.84B
-24.31
55.40%
4 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SPRY
ARS Pharmaceuticals
11.09
-1.09
-8.95%
TRVI
Trevi Therapeutics
10.76
6.98
184.66%
ORIC
Oric Pharmaceuticals
11.52
1.48
14.74%
PHAR
Pharming Group
18.16
8.64
90.66%
MAZE
Maze Therapeutics, Inc.
39.81
24.81
165.40%
SION
Sionna Therapeutics, Inc.
38.85
16.61
74.69%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts